Loading...
XNYSCC
Market cap2.64bUSD
Jan 10, Last price  
17.64USD
1D
-1.45%
1Q
-13.44%
Jan 2017
-20.14%
IPO
-11.93%
Name

Chemours Co

Chart & Performance

D1W1MN
XNYS:CC chart
P/E
—
P/S
0.44
EPS
—
Div Yield, %
5.65%
Shrs. gr., 5y
-3.99%
Rev. gr., 5y
-1.91%
Revenues
6.03b
-11.29%
7,972,000,0007,365,000,0006,859,000,0006,432,000,0005,717,000,0005,400,000,0006,183,000,0006,638,000,0005,526,000,0004,969,000,0006,345,000,0006,794,000,0006,027,000,000
Net income
-238m
L
1,431,000,0001,057,000,000423,000,000400,000,000-90,000,0007,000,000746,000,000995,000,000-52,000,000219,000,000608,000,000578,000,000-238,000,000
CFO
556m
-26.26%
1,496,000,0001,390,000,000798,000,000505,000,000182,000,000594,000,000639,000,0001,140,000,000650,000,000807,000,000820,000,000754,000,000556,000,000
Dividend
Aug 15, 20240.25 USD/sh
Earnings
Feb 26, 2025

Profile

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The company is headquartered in Wilmington, Delaware and currently employs 7,000 full-time employees. The firm operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. The company delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.
URL
https://www.chemours.com/
IPO date
Jun 19, 2015
Employees
6,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
6,027,000
-11.29%
6,794,000
7.08%
Cost of revenue
4,829,000
5,296,000
Unusual Expense (Income)
NOPBT
1,198,000
1,498,000
NOPBT Margin
19.88%
22.05%
Operating Taxes
(81,000)
163,000
Tax Rate
10.88%
NOPAT
1,279,000
1,335,000
Net income
(238,000)
-141.18%
578,000
-4.93%
Dividends
(149,000)
(154,000)
Dividend yield
3.17%
3.18%
Proceeds from repurchase of equity
(69,000)
(444,000)
BB yield
1.47%
9.16%
Debt
Debt current
106,000
25,000
Long-term debt
4,408,000
3,986,000
Deferred revenue
Other long-term liabilities
835,000
793,000
Net debt
3,153,000
2,734,000
Cash flow
Cash from operating activities
556,000
754,000
CAPEX
(370,000)
(307,000)
Cash from investing activities
(229,000)
(284,000)
Cash from financing activities
172,000
(685,000)
FCF
1,180,000
1,120,000
Balance
Cash
1,203,000
1,102,000
Long term investments
158,000
175,000
Excess cash
1,059,650
937,300
Stockholders' equity
1,512,000
1,829,000
Invested Capital
4,767,350
4,733,700
ROIC
26.92%
29.55%
ROCE
20.41%
26.13%
EV
Common stock shares outstanding
148,912
158,303
Price
31.54
3.00%
30.62
-8.76%
Market cap
4,696,697
-3.11%
4,847,238
-14.38%
EV
7,851,697
7,581,238
EBITDA
1,505,000
1,789,000
EV/EBITDA
5.22
4.24
Interest
208,000
163,000
Interest/NOPBT
17.36%
10.88%